- Home
- HROW vs PGNY Comparison
HROW vs PGNY Comparison
Compare HROW & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HROW | PGNY |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HROW | PGNY |
|---|---|---|
| Price | $40.06 | $18.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $69.86 | $26.50 |
| AVG Volume (30 Days) | 442.6K | ★ 1.2M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.04 |
| EPS | N/A | ★ 0.65 |
| Revenue | N/A | ★ $1,288,661,000.00 |
| Revenue This Year | $31.62 | $8.87 |
| Revenue Next Year | $50.77 | $9.76 |
| P/E Ratio | ★ N/A | $28.30 |
| Revenue Growth | N/A | ★ 10.40 |
| 52 Week Low | $21.18 | $16.10 |
| 52 Week High | $54.98 | $28.75 |
Technical Indicators
Market Signals| Indicator | HROW | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 54.95 | 55.46 |
| Support Level | $36.23 | $18.01 |
| Resistance Level | $41.65 | $18.79 |
| Average True Range (ATR) | 1.67 | 0.59 |
| MACD | 0.38 | 0.19 |
| Stochastic Oscillator | 68.77 | 77.95 |
Price Performance
Historical ComparisonAbout HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.